Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2025 Filed Apr 30, 2025 20:18 UTC |
Lewis Gregory PDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000067 · wk-form4_1746044271.xml · nonDerivative · entry 1 Lewis Gregory P · CIK 0001748656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,966 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 62 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:15 UTC |
Goldsmith Andrea JoDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000065 · wk-form4_1746044143.xml · nonDerivative · entry 1 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,463 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 74 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:22 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 29,574 | $0.00 Strike: $94.30 | $0.00 |
DisclosureSEC source: 0001613103-25-000029 · wk-form4_1741213320.xml · derivative · entry 4 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,574 Underlying: Ordinary Shares · 29,574 shares Expires 2035-03-03 F6 · derivative.exercise_date: The options are exercisable in four annual installments beginning one year from the date of grant. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:22 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantPerformance Share Unit · Derivative | 10,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000029 · wk-form4_1741213320.xml · derivative · entry 3 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,605 Underlying: Performance Share Units · 10,605 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Vests on April 30, 2027. F4 · derivative.expiration_date: Vests on April 30, 2027. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 10,605 shares will be issued. If maximum performance metrics are achieved, 21,210 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:22 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantOrdinary Shares | 26,512 | $94.30 | $2,500,081.60 |
DisclosureSEC source: 0001613103-25-000029 · wk-form4_1741213320.xml · nonDerivative · entry 2 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,754 F2 · shares: Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:22 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantOrdinary Shares | 4,242 | $94.30 | $400,020.60 |
DisclosureSEC source: 0001613103-25-000029 · wk-form4_1741213320.xml · nonDerivative · entry 1 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,242 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:23 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Tax withholdingOrdinary Shares | 575 | $94.30 | $54,222.50 |
DisclosureSEC source: 0001613103-25-000030 · wk-form4_1741213381.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,675 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| March 03, 2025 Filed Mar 10, 2025 21:02 UTC Amendment |
Pieton ThierryEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 29,574 | $0.00 Strike: $94.30 | $0.00 |
DisclosureSEC source: 0001613103-25-000032 · wk-form4a_1741640528.xml · derivative · entry 3 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,574 Underlying: Ordinary Shares · 29,574 shares Expires 2035-03-03 F3 · derivative.exercise_date: Form 4 filed 3/5/2025 reported incorrect vesting information for options due to an administrative error. The purpose of this amendment is to correct the vesting description to state: The options are exercisable in four equal annual installments on July 29th of 2025, 2026, 2027 and 2028. Read SEC document |
| March 03, 2025 Filed Mar 10, 2025 21:02 UTC Amendment |
Pieton ThierryEVP & Chief Financial Officer
|
GrantOrdinary Shares | 26,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000032 · wk-form4a_1741640528.xml · nonDerivative · entry 2 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,754 F2 · price: Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration. Read SEC document |
| March 03, 2025 Filed Mar 10, 2025 21:02 UTC Amendment |
Pieton ThierryEVP & Chief Financial Officer
|
GrantOrdinary Shares | 4,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000032 · wk-form4a_1741640528.xml · nonDerivative · entry 1 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,242 F1 · shares: Form 4 filed 3/5/2025 reported incorrect vesting information for restricted stock units due to an administrative error. The purpose of this amendment is to correct the vesting description to state: Represents restricted stock units that vest 100% on July 29, 2027. F2 · price: Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:10 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,337 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-25-000016 · wk-form4_1738102223.xml · derivative · entry 3 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,337 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:10 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 1,174 | $92.46 | $108,548.04 |
DisclosureSEC source: 0001613103-25-000016 · wk-form4_1738102223.xml · nonDerivative · entry 2 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,823 Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:10 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 1,337 | $74.84 | $100,061.08 |
DisclosureSEC source: 0001613103-25-000016 · wk-form4_1738102223.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 205 shares acquired through dividend reinvestment and 7 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:07 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 34,741 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-25-000014 · wk-form4_1738102030.xml · derivative · entry 3 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 34,741 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:07 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 30,184 | $92.46 | $2,790,812.64 |
DisclosureSEC source: 0001613103-25-000014 · wk-form4_1738102030.xml · nonDerivative · entry 2 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,770 Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:07 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Exercise / conversionOrdinary Shares | 34,741 | $74.84 | $2,600,016.44 |
DisclosureSEC source: 0001613103-25-000014 · wk-form4_1738102030.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 887 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:09 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,345 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-25-000015 · wk-form4_1738102153.xml · derivative · entry 3 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,345 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:09 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Tax withholdingOrdinary Shares | 2,073 | $92.46 | $191,669.58 |
DisclosureSEC source: 0001613103-25-000015 · wk-form4_1738102153.xml · nonDerivative · entry 2 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,250 Read SEC document |
| January 27, 2025 Filed Jan 28, 2025 22:09 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Exercise / conversionOrdinary Shares | 2,345 | $74.84 | $175,499.80 |
DisclosureSEC source: 0001613103-25-000015 · wk-form4_1738102153.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 632 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:35 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,437 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000009 · wk-form4_1738017322.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,437 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:35 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
SaleOrdinary Shares | 12,437 | $90.00 | $1,119,330.00 |
DisclosureSEC source: 0001613103-25-000009 · wk-form4_1738017322.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,979 Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:35 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionOrdinary Shares | 12,437 | $78.00 | $970,086.00 |
DisclosureSEC source: 0001613103-25-000009 · wk-form4_1738017322.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 271 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:02 UTC |
Corona Gary LouisInterim CFO
|
GrantOrdinary Shares | 11,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000007 · wk-form4_1737669718.xml · nonDerivative · entry 1 Corona Gary Louis · CIK 0002032288 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,255 F1 · shares: Represents restricted stock units that vest 100% on the first anniversary of the date of grant. F2 · balance_after: Includes 219 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,850 | $0.00 Strike: $74.84 | $0.00 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,850 shares Expires 2025-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
SaleOrdinary Shares | 3,000 | $80.41 | $241,230.00 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,708 Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
SaleOrdinary Shares | 6,850 | $80.41 | $550,808.50 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,708 Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:48 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionOrdinary Shares | 6,850 | $74.84 | $512,654.00 |
DisclosureSEC source: 0001613103-25-000003 · wk-form4_1736545728.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 645 | $82.48 | $53,199.60 |
DisclosureSEC source: 0001613103-24-000179 · wk-form4_1734472828.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,708 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 247 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:59 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 532 | $82.48 | $43,879.36 |
DisclosureSEC source: 0001613103-24-000176 · wk-form4_1734472741.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,692 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 21:59 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
Tax withholdingOrdinary Shares | 4,417 | $82.48 | $364,314.16 |
DisclosureSEC source: 0001613103-24-000177 · wk-form4_1734472772.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,326 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility. F2 · balance_after: Includes 829 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 22:00 UTC |
Salmon SeanEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 645 | $82.48 | $53,199.60 |
DisclosureSEC source: 0001613103-24-000178 · wk-form4_1734472797.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,722 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2 · balance_after: Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 17:01 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 3,009 | $83.58 | $251,492.22 |
DisclosureSEC source: 0001613103-24-000171 · wk-form4_1733954499.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,224 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:43 UTC |
Corona Gary LouisInterim CFO
|
Tax withholdingOrdinary Shares | 662 | $84.01 | $55,614.62 |
DisclosureSEC source: 0001613103-24-000167 · wk-form4_1733780618.xml · nonDerivative · entry 1 Corona Gary Louis · CIK 0002032288 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,721 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 213 shares acquired through dividend reinvestment and 135 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:51 UTC |
Kirk Jennifer MChief Accounting Officer
|
Tax withholdingOrdinary Shares | 646 | $84.01 | $54,270.46 |
DisclosureSEC source: 0001613103-24-000169 · wk-form4_1733867491.xml · nonDerivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,011 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 153 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 20:11 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
Tax withholdingOrdinary Shares | 2,045 | $85.38 | $174,602.10 |
DisclosureSEC source: 0001613103-24-000142 · wk-form4_1724271082.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,346 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:20 UTC |
Corona Gary LouisInterim CFO
|
GrantOrdinary Shares | 8,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000136 · wk-form4_1724098818.xml · nonDerivative · entry 1 Corona Gary Louis · CIK 0002032288 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,035 F1 · shares: Represents restricted stock units that vest in two annual installments beginning one year from the date of grant. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:15 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 684 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000119 · wk-form4_1722982529.xml · derivative · entry 4 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 684 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:15 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 231 | $81.51 | $18,828.81 |
DisclosureSEC source: 0001613103-24-000119 · wk-form4_1722982529.xml · nonDerivative · entry 3 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,448 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:15 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 210 | $81.51 | $17,117.10 |
DisclosureSEC source: 0001613103-24-000119 · wk-form4_1722982529.xml · nonDerivative · entry 2 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,679 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:15 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Exercise / conversionOrdinary Shares | 684 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000119 · wk-form4_1722982529.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionPerformance Share Units · Derivative | 5,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 5,311 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 2,701 | $81.51 | $220,158.51 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,106 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 2,362 | $81.51 | $192,526.62 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,807 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:16 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Exercise / conversionOrdinary Shares | 5,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000120 · wk-form4_1722982576.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Exercise / conversionPerformance Share Units · Derivative | 6,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · derivative · entry 7 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 6,144 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Exercise / conversionPerformance Share Units · Derivative | 8,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · derivative · entry 6 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Performance Share Units · 8,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 2, 2024. F5 · derivative.expiration_date: The performance share units vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 2,985 | $81.51 | $243,307.35 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 5 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,963 F3 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 2,802 | $81.51 | $228,391.02 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 4 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,948 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units units that vested on August 2, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Exercise / conversionOrdinary Shares | 6,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 3 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on February 1, 2022 and earned dividend equivalents. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 18:11 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 3,423 | $81.51 | $279,008.73 |
DisclosureSEC source: 0001613103-24-000111 · wk-form4_1722982277.xml · nonDerivative · entry 2 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,606 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units units that vested on August 2, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.